GEOVAX LABS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
GEOVAX LABS, INC. (GOVX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $209.82 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-23.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-23
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $209.82K.
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-06-30 was $457.83K.
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-12-31 was $0.00.
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-09-30 was $0.00.
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $209.82K, a 54.17% decline from fiscal 2020.
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $457.83K.
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2013 was $1.13M.
- GEOVAX LABS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2011 was $159.25K, a 31.55% increase from fiscal 2010.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2021-12-31 | $209.82K 10-K · filed 2023-03-23 | |||
| 2021-09-30 | $209.82K 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $457.83K 10-K · filed 2022-03-09 | |||
| 2020-06-30 | $457.83K 10-Q · filed 2021-08-11 | |||
| 2013-12-31 | $1.13M 10-K · filed 2014-03-14 | |||
| 2012-12-31 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $1.13M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13 | $1.13M 10-Q · filed 2012-11-13 | ||
| 2012-06-30 | $1.13M 10-Q · filed 2012-08-13 | |||
| 2011-12-31 | $159.25K 10-K · filed 2012-03-30 | |||
| 2010-12-31 | $121.06K 10-K · filed 2012-03-30 | |||
| 2009-12-31 | $45.40K 10-K · filed 2012-03-30 | |||
| 2008-12-31 | $146.88K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |